Close Menu

At In the Pipeline, Derek Lowe takes a walk down memory lane -- the late '80s and early '90s -- of the biopharma industry, when computers were considered a luxury and data sharing meant one person hoarding the goods on a mainframe. He talks of the "Bare Desk Era" at his first company, when no computers were official policy and registering new chemical compounds was done with pencil and paper and interoffice mail.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.